Usage and safety of topical tacrolimus in patients with mycosis fungoides
Clin Exp Dermatol
.
2022 Jun;47(6):1200-1201.
doi: 10.1111/ced.15162.
Epub 2022 Apr 1.
Authors
David M Weiner
1
,
Ashley K Clark
2
,
Rahul S Bhansali
3
,
Lisa Pappas-Taffer
2
,
Stefan K Barta
3
,
Jennifer Villasenor-Park
2
,
Paul L Haun
2
,
Carmela C Vittorio
2
,
Alain H Rook
2
,
Ellen J Kim
2
,
Sara S Samimi
2
Affiliations
1
Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
2
Department of Dermatology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.
3
Department of Hematology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.
PMID:
35245947
DOI:
10.1111/ced.15162
No abstract available
Publication types
Letter
MeSH terms
Humans
Mycosis Fungoides* / drug therapy
Skin Neoplasms* / drug therapy
Tacrolimus / adverse effects
Substances
Tacrolimus